Literature DB >> 11730364

Regulation of nitric oxide production by murine peritoneal macrophages treated in vitro with chemokine monocyte chemoattractant protein 1.

S K Biswas1, A Sodhi, S Paul.   

Abstract

Monocyte chemoattractant protein 1 (MCP-1) is an important mediator of monocyte/macrophage recruitment and activation at the sites of chronic inflammation and neoplasia. In the current study, the role of nitrogen monoxide (NO) in the activation of murine peritoneal macrophages to the tumoricidal state in response to in vitro MCP-1 treatment and the regulatory mechanisms involved therein were investigated. Murine peritoneal macrophages upon activation with MCP-1 showed a dose- and time-dependent production of NO together with increased tumoricidal activity against P815 mastocytoma cells. N-monomethyl-l-arginine (L-NMMA), a specific inhibitor of the l-arginine pathway, inhibited the MCP-1-induced NO secretion and generation of macrophage-mediated tumoricidal activity against P815 (NO-sensitive, TNF-resistant) cells but not the L929 (TNF-sensitive, NO-resistant) cells. These results indicated l-arginine-dependent production of NO to be one of the effector mechanisms contributing to the tumoricidal activity of MCP-1-treated macrophages. Supporting this fact, expression of iNOS mRNA was also detected in the murine peritoneal macrophages upon treatment with MCP-1. Investigating the signal transduction pathway responsible for the NO production by the MCP-1-activated murine peritoneal macrophages, it was observed that the pharmacological inhibitors wortmannin, H-7 (1-(5-isoquinoline sulfonyl)-2-methyl piperazine dihydrochloride), and PD98059 blocked the MCP-1-induced NO production, suggesting the probable involvement of phosphoinositol-3-kinase, protein kinase C, and p42/44 MAPkinases in the above process. Various modulators of calcium and calmodulin (CaM) such as EGTA, nifedipine, TMB-8 (3,4,5-trimethoxybenzoic acid-8-(diethylamino)octyl ester), A23187, and W-7 (N-(6-aminohexyl)-5-chloro-1-napthalenesulfonamide) were also found to modulate the in vitro macrophage NO release in response to MCP-1. This observation indicated the regulatory role of calcium/CaM in the process of MCP-1-induced macrophage NO production. Similarly, the role of serine/threonine and protein tyrosine phosphatases in the above pathway was suggested using the specific inhibitors of these phosphatases, okadaic acid and sodium orthovanadate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11730364     DOI: 10.1006/niox.2001.0370

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  14 in total

1.  Leishmanicidal activities of novel methylseleno-imidocarbamates.

Authors:  Celia Fernández-Rubio; Daphne Campbell; Andrés Vacas; Elena Ibañez; Esther Moreno; Socorro Espuelas; Alfonso Calvo; Juan Antonio Palop; Daniel Plano; Carmen Sanmartin; Paul A Nguewa
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

2.  Relevance of Helicobacter pylori genotypes in gastric pathology and its association with plasma malondialdehyde and nitric oxide levels.

Authors:  Santosh K Tiwari; G Manoj; Vishwas Sharma; G Sivaram; R Saikant; Avinash Bardia; Varun K Sharma; Zakia Abid; Aleem A Khan; M Aejaz Habeeb; C M Habibullah; B Santhosh Kumar; Amrita Nandan
Journal:  Inflammopharmacology       Date:  2010-02-09       Impact factor: 4.473

3.  Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages.

Authors:  Sean M Conrad; Dalit Strauss-Ayali; Ann E Field; Matthias Mack; David M Mosser
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

4.  Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice.

Authors:  F Y Chow; D J Nikolic-Paterson; F Y Ma; E Ozols; B J Rollins; G H Tesch
Journal:  Diabetologia       Date:  2006-12-12       Impact factor: 10.122

5.  Bacterial clearance in septic mice is modulated by MCP-1/CCL2 and nitric oxide.

Authors:  Rachel N Gomes; Mariana G A Teixeira-Cunha; Rodrigo T Figueiredo; Patricia E Almeida; Silvio C Alves; Patrícia T Bozza; Fernando A Bozza; Marcelo T Bozza; Guy A Zimmerman; Hugo C Castro-Faria-Neto
Journal:  Shock       Date:  2013-01       Impact factor: 3.454

6.  Nitric oxide and MCP-1 regulation in LPS activated rat Kupffer cells.

Authors:  George Kolios; Vassilis Valatas; Pinelopi Manousou; Costas Xidakis; George Notas; Elias Kouroumalis
Journal:  Mol Cell Biochem       Date:  2008-07-16       Impact factor: 3.396

7.  Catechin induced modulation in the activities of thyroid hormone synthesizing enzymes leading to hypothyroidism.

Authors:  Amar K Chandra; Neela De
Journal:  Mol Cell Biochem       Date:  2012-11-02       Impact factor: 3.396

8.  Pimaradienoic Acid Inhibits Carrageenan-Induced Inflammatory Leukocyte Recruitment and Edema in Mice: Inhibition of Oxidative Stress, Nitric Oxide and Cytokine Production.

Authors:  Sandra S Mizokami; Miriam S N Hohmann; Larissa Staurengo-Ferrari; Thacyana T Carvalho; Ana C Zarpelon; Maria I Possebon; Anderson R de Souza; Rodrigo C S Veneziani; Nilton S Arakawa; Rubia Casagrande; Waldiceu A Verri
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

9.  Bacterial clearance is improved in septic mice by platelet-activating factor-acetylhydrolase (PAF-AH) administration.

Authors:  Mariana G A Teixeira-da-Cunha; Rachel N Gomes; Nathassia Roehrs; Fernando A Bozza; Stephen M Prescott; Diana Stafforini; Guy A Zimmerman; Patricia T Bozza; Hugo C Castro-Faria-Neto
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

10.  Leishmania donovani-Induced Increase in Macrophage Bcl-2 Favors Parasite Survival.

Authors:  Rajeev Kumar Pandey; Sanjana Mehrotra; Smriti Sharma; Ramachandra Subbaraya Gudde; Shyam Sundar; Chandrima Shaha
Journal:  Front Immunol       Date:  2016-10-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.